MTB0 Stock Chart & Stats
€1.78
>-€0.01(-0.22%)
At close: 4:00 PM EDT
€1.78
>-€0.01(-0.22%)
Day’s Range― - ―
52-Week Range€1.68 - €3.50
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€89.90M
Enterprise Value€156.91
Total Cash (Recent Filing)€3.85M
Total Debt (Recent Filing)€5.74M
Price to Earnings (P/E)30.7
Beta0.73
Next Earnings
Aug 06, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding42,492,950
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)18.55
Price to Sales (P/S)9.16
P/FCF Ratio53.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.55Price Target Upside155.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.16
Revenue Forecast (FY)€115.12M
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent operating cash flow and TTM free cash flow roughly matching net income indicate durable cash conversion. This supports funding integrations, product development and working capital needs without constant external financing, improving long-term operational flexibility.
Capital Structure SimplificationFull redemption of Series B and a $50M facility simplify capital structure and remove preferred dividend overhang. Lower structural claims on cashflow and clearer equity base enhance financial flexibility and investor alignment over multiple quarters.
AI Commercialization And TAM ExpansionDemonstrated commercial traction with StratusAI automating a large portion of inbound calls signals scalable tech-led revenue. AI capability and commercialization expand addressable services, enable higher gross retention and cross-sell, and support durable margin improvement over time.
Bears Say
Gross-margin CompressionSustained gross-margin compression reduces the firm’s ability to convert revenue growth into durable profit expansion. If driven by mix shifts or higher service costs, this pressure can persist through integrations and limit longer-term operating margin improvement.
Integration & Amortization HeadwindsLarge acquisition-related amortization and resource-intensive modernization (Medsphere modernization and carryforward items) create multi-quarter earnings drag. These structural integration demands delay cross-sell synergies and sustained margin recovery until platforms are modernized.
Free Cash Flow And Liquidity PressureDeclining free cash flow plus modest cash balances and new debt service obligations raise the risk of persistent liquidity constraints. Reduced FCF weakens the buffer for integration spending and makes execution on modernization and cross-sell initiatives more balance-sheet sensitive.
CareCloud News
MTB0 FAQ
What was CareCloud’s price range in the past 12 months?
CareCloud lowest stock price was €1.68 and its highest was €3.50 in the past 12 months.
What is CareCloud’s market cap?
CareCloud’s market cap is €89.90M.
When is CareCloud’s upcoming earnings report date?
CareCloud’s upcoming earnings report date is Aug 06, 2026 which is tomorrow.
How were CareCloud’s earnings last quarter?
CareCloud released its earnings results on May 07, 2026. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of -€0.006 by -€0.003.
Is CareCloud overvalued?
According to Wall Street analysts CareCloud’s price is currently Undervalued.
Does CareCloud pay dividends?
CareCloud does not currently pay dividends.
What is CareCloud’s EPS estimate?
CareCloud’s EPS estimate is 0.02.
How many shares outstanding does CareCloud have?
CareCloud has 42,492,950 shares outstanding.
What happened to CareCloud’s price movement after its last earnings report?
CareCloud reported an EPS of -€0.009 in its last earnings report, missing expectations of -€0.006. Following the earnings report the stock price went up 5.053%.
Which hedge fund is a major shareholder of CareCloud?
Currently, no hedge funds are holding shares in DE:MTB0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareCloud Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€4.55 (155.75% Upside)
€4.55 (155.75% Upside)
Blogger Sentiment
Bullish
DE:MTB0 Sentiment 100%
Sector Average 65%
Sector Average 65%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.32%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.90%
Trailing 12-Months
Company Description
CareCloud
CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the United States. The company strategically organizes its activities into two core divisions: Healthcare IT and Medical Practice Management. Through its Software-as-a-Service (SaaS) platform, CareCloud provides essential tools for managing revenue cycles, administering practices, handling electronic health records, gleaning business insights, facilitating telehealth, and enhancing patient engagement. These offerings, complemented by various software utilities and tailored business services, are designed to empower diverse medical groups and health systems. Professionals such as doctors, nurses, physician assistants, and other clinical staff who render billable services are among its key users. Established in 1999 and based in Somerset, New Jersey, the entity was originally named MTBC, Inc. before officially adopting CareCloud, Inc. in March 2021.
MTB0 Company Deck
MTB0 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and strategic picture: double-digit revenue growth (13% Y/Y), commercialization and scaling of AI products (StratusAI handling ~75% of inbound calls for early adopters), successful capital structure simplification (new $50M facility and Series B redemption with no common dilution), and reaffirmation of full-year guidance with a forecasted >100% EPS improvement versus 2025. Offsetting these positives are near-term integration and amortization headwinds from the Medsphere acquisition, a drop in free cash flow and modest declines in certain adjusted metrics; management expects margins and cash generation to improve as integration and amortization effects subside and AI and cross-sell synergies ramp in the back half of the year. On balance, the call conveys momentum and clear strategic progress despite expected short-term integration costs.View all DE:MTB0 earnings summariesMTB0 Stock 12 Month Forecast
Average Price Target
€4.55
▲(155.75% Upside)
Technical Analysis
Evolent Health
―
Phreesia
―
Health Catalyst
―
American Well
―
Waystar Holding Corp.
―